Showing results (221-230 of 247) with videos related to
Sort By:
Pageof 25
Theranostics|January 3, 2024
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcriptionIelizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapyShivaprasad Patil, Annett Linge, Marianne Grosser, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 25, 2017
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapyChiara De-Colle, Apostolos Menegakis, David Mönnich, et al.International Journal of Cancer|December 14, 2017
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Stefan Stangl, Nikoletta Tontcheva, Wolfgang Sievert, et al.The Journal of Molecular Diagnostics : JMD|April 6, 2020
Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell CarcinomaStefan Schmidt, Annett Linge, Marianne Grosser, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2023
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenograftsAnnett Linge, Shivaprasad Patil, Marianne Grosser, et al.Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanismIelizaveta Gorodetska, Vasyl Lukiyanchuk, Marta Gawin, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 4, 2018
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCCAnnett Linge, Ulrike Schötz, Steffen Löck, et al.Cancers|August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapyShivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.Pageof 25